SB 2212 – Texas
Status: Inactive / DeadYear Introduced: 2023
Link: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=88R&Bill=SB2212
Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Key Issues:
PRICE AND QUALITY TRANSPARENCY
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found